Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0235974|pancreatic cancer |
Sentences | 2 |
PubMedID- 21954965 | These data are promising for the future application of this drug regimen in patients with pancreatic cancer. |
PubMedID- 21969517 | Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase i/ii trial. |
Page: 1